AJTMH HINARI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am. J. Trop. Med. Hyg., 75(5), 2006, pp. 964-967
Copyright © 2006 by The American Society of Tropical Medicine and Hygiene

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (2)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by GLICKSTEIN, L. J.
Right arrow Articles by COBURN, J. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by GLICKSTEIN, L. J.
Right arrow Articles by COBURN, J. L.
Related Collections
Right arrow Borrelia
Right arrow Lyme Disease

SHORT REPORT


ASSOCIATION OF MACROPHAGE INFLAMMATORY RESPONSE AND CELL DEATH AFTER IN VITRO BORRELIA BURGDORFERI INFECTION WITH ARTHRITIS RESISTANCE

LISA J. GLICKSTEIN* AND JENIFER L. COBURN
Center for Immunology and Inflammatory Diseases, Massachusetts General Hospital, Boston, Massachusetts; Division of Geographic Medicine and Infectious Diseases, Tufts-New England Medical Center, Boston, Massachusetts

 

ABSTRACT

Susceptibility to Borrelia burgdorferi infection and subsequent arthritis is genetically determined in mice and determined by innate immunity. Accordingly, macrophage responses to B. burgdorferi challenge may differ between mouse strains. Bone marrow–derived macrophages were infected ex vivo with clonal B. burgdorferi strain N40. Interleukin-12 and tumor necrosis factor-{alpha} (TNF-{alpha}) production were higher in macrophages from resistant C57Bl/6 mice than in macrophages from susceptible C3H/HeJ mice. However, TNF-{alpha} production was observed in lower concentrations in C3H/HeJ (toll-like receptor-4–/–) macrophages than in C3H/FeJ (TLR4+/+) macrophages, suggesting that TLR4 might contribute to the response to B. burgdorferi. A higher cytokine response to B. burgdorferi was associated with cell death in macrophages from resistant C57Bl/6 mice. Understanding variability in the response of macrophages to B. burgdorferi may contribute to understanding Lyme arthritis.


Borrelia burgdorferi, a causative agent of Lyme disease, causes inflammatory arthritis and joint edema in susceptible mouse strains, particularly C3H.1 Susceptibility is dominant and associated with large numbers of spirochetes in tissues.2 Adaptive immunity controls spirochete burden, but even if this response is absent and there are large numbers of spirochetes in the joints, severe inflammatory joint infiltrates do not occur in C57BL/6 mice,3 suggesting a protective effect by the innate immune system. In C57BL/6 beige mice, which have gross defects in innate immunity, severe arthritis follows B. burgdorferi infection.1 Genetic control of acute Lyme arthritis severity in mice maps to a number of chromosomal regions, some of which encode regulators of innate immunity.4 Macrophage function has been proposed to be critical for mice to combat B. burgdorferi infection.1 Borrelia burgdorferi lipoproteins are mitogenic for murine monocytes5 through stimulation of toll-like receptors (TLR) 1 and 2.6 In addition, non–lipopeptide-derived signals induce tumor necrosis factor-{alpha} (TNF-{alpha}), chemokines, and interleukin-6 (IL-6) through the Fc{gamma} receptor.7 Levels of TNF-{alpha} are elevated in sera and synovial fluids of Lyme borreliosis patients,8 and lipoproteins induce TNF-{alpha} production from elicited peritoneal macrophages.5 Interleukin-12, a cytokine required for the induction of cellular immunity in response to infection,9 has been reported in response to B. burgdorferi in human patients10 and in murine macrophages ex vivo.11 Although it was previously shown that peritoneal macrophages engulf B. burgdorferi and degrade the spirochetes in intracellular compartments,12 and produce TNF-{alpha} in response to lipoprotein stimulation,5 macrophage cytokine production after ex vivo infection with B. burgdorferi has not yet been associated with arthritis susceptibility. We tested the hypothesis that the pro-inflammatory macrophage response to B. burgdorferi is mouse strain-dependent.

Female, six-week-old C57BL/6J, 129S7/J, C3H/HeJ, and C3H/FeJ mice were obtained from the Jackson Laboratories (Bar Harbor, ME) and housed in the Tufts-New England Medical Center Department of Laboratory Animal Medicine (Boston, MA). The maintenance and care of experimental animals complied with the National Institutes of Health guidelines for the humane use of laboratory animals, and all procedures were conducted under an institutional animal care and use committee–approved protocol.

A murine fibroblast line, ATCC CCL 1 (L cells), was cultured in RPMI 1640 medium plus 10% heat-inactivated fetal bovine serum (FBS), 2 mM glutamine, 100 units/mL of penicillin G, and 100 µg/mL of streptomycin sulfate (L/M{phi} medium; Gibco/Invitrogen, Gaithersburg, MD) at 37°C in an atmosphere of 5% CO2. L cell–conditioned medium (a source of macrophage colony stimulating factor) was harvested one day after the cells reached > 90% confluence and filtered through a 0.22-µm filter prior to use.

Primary cultures of bone marrow–derived macrophages were prepared as previously described.11 Marrow from four femurs (two mice) per strain was pooled for each experiment. The cell pellet was resuspended in RPMI 1640 medium supplemented with glutamine, penicillin, and streptomycin as above, 10% FBS, and 30% L cell–conditioned medium (BMM{phi} medium). The cells were plated with 4 x 106 cells/ 100-mm untreated plastic dish in 10 mL of BMM{phi} medium and incubated at 37°C in an atmosphere of 5% CO2. Plates were fed on day 3 by adding 10 mL of fresh BMM{phi} medium and replated on day 5 into L/M{phi} medium with 5 x 105 cells/ well (six-well tissue culture plates) or 1.25 x 105 cells/well (24-well plate containing 12-mm round glass coverslips). Plates were incubated at 37°C in an atmosphere of 5% CO2 for two days before infection on day 7.

Borrelia burgdorferi strain N40 clone D10/E913 was grown in modified Kelley medium (MKP) supplemented with human serum in place of rabbit serum, aliquoted, and frozen at passage 11 at –80°C until use as previously described.14 Borrelia burgdorferi grown in MKP with human serum are routinely used for infection of mammalian cells in culture because they bind to integrins more efficiently than when grown in Barbour-Stoenner-Kelly medium. Thawed spirochetes were washed twice at ambient temperature in phosphate-buffered saline (PBS) with 0.2% bovine serum albumin (BSA) and resuspended at a concentration of 1.67 x 107 spirochetes/mL (to achieve a multiplicity of infection [MOI] of 100 bacteria per macrophage) in L/m{phi} medium without antibiotics. Ten-fold serial dilutions of this culture into L/m{phi} medium achieved MOIs of 10 and 1. The L/m{phi} medium without antibiotics served as the control (MOI = 0).

Medium was removed from plated macrophages, and the cells were washed once with PBS to remove antibiotics. Spirochetes were added (3 mL/well of each 6-well plate, 0.75 mL/well of each 24-well plate), and plates were centrifuged (540 x g) for 15 minutes at room temperature to maximize bacteria-macrophage contact. The plates were incubated at 37°C in an atmosphere of 5% CO2.

Monensin (Sigma, St. Louis, MO) was added to six-well plates to a final concentration of 3 µM after incubation as described above, and plates were incubated for one hour at 37°C in an atmosphere of 5% CO2. Cells were harvested by washing plates once with PBS, incubating for 5 minutes at 37°C with 0.5 mL of trypsin/EDTA (Gibco/Invitrogen), scraping from the plates, and pooling contents from duplicate wells. Cells (105/well) were aliquoted into a 96-well V-bottom plate for staining using the intracytoplasmic cytokine kit (BD Biosciences Pharmingen, San Diego, CA). Briefly, cells were fixed in Cytofix/Cytoperm (BD Biosciences Pharmingen) for 15 minutes at 4°C, washed once with Perm/Wash (BD Biosciences Pharmingen), and incubated with antibodies to cytokines (1:100 anti–IL-12 phycoerythrin [PE] or anti–TNF-{alpha} PE in Perm/Wash; BD Biosciences Pharmingen) for 15 minutes at 4°C. Cells were washed twice with Perm/Wash and resuspended in PBS with 2% FBS and 0.1% sodium azide for analysis on a FACSCalibur cytometer (BD Biosciences Pharmingen). Forward and side scatter gating excluded dead cells and debris. The C57Bl/6 and C3H/He mice were compared in four experiments. Results are presented as the mean ± SD for each MOI. Groups were compared by two-way analysis of variance (ANOVA) (Sigma Stat; SPSS, Inc., Chicago, IL). The 129/J and C3H/Fe macrophages were included for comparison in one experiment. Dose-dependent production of IL-12 was secreted from the C57BL/6J and 129-derived macrophages, but at a significantly lower level from the C3H mouse strain macrophages (P = 0.003) (Figure 1AGo).


Figure 1
View larger version (19K):
[in this window]
[in a new window]

 
    FIGURE 1. Cytokine production by ex vivo infected macrophages from C57BL/6J (arthritis-resistant), 129/J (intermediate), and C3H/ HeJ and C3H/FeJ (susceptible) mice. Bone marrow–derived macrophages were prepared and infected for three hours with Borrelia burgdorferi at multiplicities of infection (MOIs) of 0, 1, 10, and 100 bacteria/cell. Macrophages were incubated for an additional one hour with monensin to retard protein secretion, and then stained for flow cytometric analysis of A, intracellular interleukin-12 (IL-12) and B, tumor necrosis factor-{alpha} (TNF-{alpha}). Five thousand to 10,000 events were acquired per sample. Mean ± SD percent values of cytokine-positive live cells in culture, from up to four experiments per strain (all available data) are indicated. Values indicated by an asterisk (*) for C57Bl/6J macrophages were significantly greater than those of C3H/HeJ mice at the same MOI by two-way analysis of variance (P = 0.003).

 
Tumor necrosis factor-{alpha} was induced by B. burgdorferi infection at an MOI of 100 (P = 0.006). Of interest, TNF-{alpha} was present at a lower level in C3H/HeJ (TLR4–/–) macrophages than C3H/FeJ (TLR4+/+) macrophages (Figure 1BGo). Neither TNF-{alpha} production nor IL-12 production was attributable to endotoxin contamination because the Limulus amebocyte lysate assay (Cambrex Bio Science Inc., Walkersville, MD) showed a low level of endotoxin (10.8 EU/mL) in the media and buffers used, which is below the level of 150 EU/mL reported previously to stimulate macrophages.15 Since B. burgdorferi does not produce lipopolysaccharide, the classic TLR4 agonist, the differences in TNF-{alpha} production by the C3H/HeJ versus C3H/FeJ cultures suggest a novel TLR4-dependent immediate early macrophage response to some other component of B. burgdorferi.

Because a stronger pro-inflammatory cytokine response was paradoxically mounted by macrophages from mouse strains that do not develop significant arthritis, we tested the possibility of mouse strain-dependent susceptibility to B. burgdorferi-induced macrophage death. Infected macrophages were simultaneously incubated with a fluorescent dye that stains nuclei, as well as one that generates a green fluorescent signal only after cleavage by esterases within viable cells, to enumerate live cells as a function of MOI.

Twenty-four–well plates containing macrophage monolayers on coverslips were removed from the incubator after three hours hr and washed twice with PBS. CellTracker Green (10 µM 5-chloromethylfluorescein diacetate; Invitrogen, Carlsbad, CA) and 6-diamidino-2-phenylindole dihydrochloride (0.02 µg/mL; Invitrogen) in RPMI 1640 medium were added to the monolayer and incubation was continued for 30 minutes. Plates were then washed twice with PBS, fixed with 0.5 mL paraformaldehyde (3% in PBS; Sigma), washed twice with PBS, and stored overnight at 4°C in 1 mL of PBS with 1% BSA and 3% normal goat serum. Coverslips were rinsed with PBS and mounted onto slides using the ProLong anti-fade kit (Invitrogen) according to manufacturer’s instructions. Adherent cells were scored as live (faint blue nuclei and green cytoplasm) or dead (blue nuclei and unstained cytoplasm) for three fields per coverslip in two independent experiments. To facilitate comparisons between experiments, the number of live cells for each MOI (1, 10, and 100) was normalized to the number at MOI = 0 to obtain percent live cells. The values were compared between groups by two-way ANOVA and pairwise comparisons were made between groups by the Holm-Sidak method (Sigma Stat).

A significant decrease in the proportion of adherent live cells was observed in C57Bl/6 macrophages but not in C3H/ HeJ macrophages at an MOI ≥ 1 (Figure 2Go). Many rounded-up cells were additionally noted prior to washing the cover-slips in these wells. Thus, B. burgdorferi infection induced cell detachment and death in macrophages from C57Bl/6 mice, but not from C3H/He mice. Cell death has previously been associated with inflammatory cytokine production in macrophages infected with Mycobacterium tuberculosis,16 as well as in T cells, and may be functionally linked.17


Figure 2
View larger version (11K):
[in this window]
[in a new window]

 
    FIGURE 2. Cell death versus survival of ex vivo–infected macrophages from C57Bl/6 (arthritis-resistant) and C3H/HeJ (arthritis-susceptible) mice. Bone marrow–derived macrophages were prepared and infected for three hours with Borrelia burgdorferi at multiplicities of infection (MOIs) of 1, 10, and 100 bacteria per cell, or incubated with medium alone (MOI = 0). Macrophages were incubated for an additional 30 minutes with CellTracker Green (10 µM 5-chloromethylfluorescein diacetate) and 6-diamidino-2-phenylindole dihydrochloride, and then fixed and mounted on slides for analysis of live or dead cells. Percent live cells was calculated as live cells in infected macrophage samples divided by live cells in MOI = 0 samples. Values are averages from triplicate wells in two independent experiments. Error bars show the mean ± SD. Values indicated by an asterisk (*) for the C57Bl/6J-derived macrophages are significantly lower than those of C3H/HeJ mice at the same MOI by two-way analysis of variance (P = 0.006).

 
Innate immunity provides the first line of defense against B. burgdorferi infection. Our data predict that an initial robust inflammatory response would be beneficial in controlling the number of organisms. These results support in vivo studies18,19 that suggested that infection in susceptible C3H mice would lead to an attenuated macrophage cytokine response. Arthritis susceptibility in C3H/FeJ mice after B. burgdorferi infection has not been reported; however, other TLR4+/+ strains, including C3H/HeSnSmn20 and C3H/HeN21 mice, were susceptible to experimental Lyme arthritis. Multiple genetic loci control arthritis susceptibility in B. burgdorferi-infected mice.22 Macrophages from both C57BL/6 and C3H mice were able to phagocytose spirochetes and inert particles (Glickstein LJ and Coburn JL, unpublished data), but the recruitment of leukocytes would be initially impaired in the C3H/HeJ mice. Even with lipoprotein stimulation of inflammation through TLR1 and TLR2 and other pathways, this might provide the bacteria with additional time to adopt the host-adapted state.

A functional innate immune response is required for arthritis resistance in C57Bl/6 mice, and blocking the macrophage inhibitory cytokines IL-6 and IL-10 exacerbates arthritis in this strain. A beneficial inflammatory response may be self-limited by B. burgdorferi-induced apoptosis, production of anti-inflammatory cytokines, or both. Resistance to Lyme arthritis may therefore depend on an effective early cytokine release by macrophages and temporal limitation of the immune reaction by ensuing macrophage apoptosis. Understanding mouse strain-specific variability in the response of macrophages to B. burgdorferi may contribute to understanding the earliest steps in the development of Lyme arthritis.


Received May 3, 2006. Accepted for publication June 23, 2006.

Acknowledgments: We thank Dr. Linden Hu for helpful discussions, and Dr. Georg Weber for many insightful suggestions on the manuscript.

Financial support: Lisa J. Glickstein was supported by a grant from the Harold G. and Leila Y. Mathers Foundation. Jenifer L. Coburn was supported by a biomedical science grant from the Arthritis Foundation, National Institutes of Health grants AI-40938 and AI-051407, and by Public Health Service grant 1 P30DK39428 awarded by the National Institute of Diabetes and Digestive and Kidney Diseases to the Center for Gastroenterology Research on Absorptive and Secretory Processes at Tufts-New England Medical Center.

* Address correspondence to Lisa J. Glickstein, Massachusetts General Hospital, 149 13th Street, Room 8301, Charlestown, MA, 02129. E-mail: lglickstein{at}partners.org Back

Authors’ addresses: Lisa J. Glickstein, Massachusetts General Hospital, 149 13th Street, Room 8301, Charlestown, MA, 02129, Telephone: 617-726-1529, Fax: 617-726-1544, E-mail: lglickstein{at}partners.org. Jenifer L. Coburn, Tufts-New England Medical Center, 750 Washington Street, NEMC Box 41, Boston, MA, 02111, Telephone: 617-636-5952, Fax: 617-636-3216, E-mail: jcoburn{at}tufts-nemc.org.

 

REFERENCES

  1. Barthold SW, 1996. Lyme borreliosis in the laboratory mouse. J Spirochetal Tick-Borne Dis 3: 22–44.
  2. Yang L, Weis JH, Eichwald E, Kolbert CP, Persing DH, Weis JJ, 1994. Heritable susceptibility to severe Borrelia burgdorferi-induced arthritis is dominant and is associated with persistence of large numbers of spirochetes in tissues. Infect Immun 62: 492–500.[Abstract/Free Full Text]
  3. Ma Y, Seiler KP, Eichwals EJ, Weis JH, Teuscher C, Weiss JJ, 1998. Distinct characteristics of resistance to Borrelia burgdorferi-induced arthritis in C57BL/6N mice. Infect Immun 66: 161–168.[Abstract/Free Full Text]
  4. Weis JJ, 2002. Host-pathogen interactions and the pathogenesis of murine Lyme disease. Curr Opin Rheumatol 14: 399–403.[ISI][Medline]
  5. Radolf JD, Arndt LL, Akins DR, Curetty LL, Levi ME, Shen Y, Davis LS, Norgard MV, 1995. Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides activate monocytes/macrophages. J Immunol 154: 2866–2877.[Abstract]
  6. Wooten RM, Ma Y, Yoder RA, Brown JP, Weis JH, Zachary JF, Kirschning CJ, Weis JJ, 2002. Toll-like receptor 2 is required for innate, but not acquired, host defense to Borrelia burgdorferi. J Immunol 168: 348–355.[Abstract/Free Full Text]
  7. Talkington J, Nickell SP, 2001. Role of Fc gamma receptors in triggering host cell activation and cytokine release by Borrelia burgdorferi. Infect Immun 69: 413–419.[Abstract/Free Full Text]
  8. Defosse DL, Johnson RC, 1992. In vitro and in vivo induction of tumor necrosis factor alpha by Borrelia burgdorferi. Infect Immun 60: 1109–1113.[Abstract/Free Full Text]
  9. Biron CA, Gazzinelli RT, 1995. Effects of IL-12 on immune responses to microbial infections: a key mediator in regulating disease outcome. Curr Opin Immunol 7: 485–496.[ISI][Medline]
  10. Grusell M, Widhe M, Ekerfelt C, 2002. Increased expression of the Th1-inducing cytokines interleukin-12 and interleukin-18 in cerebrospinal fluid but not in sera from patients with Lyme neuroborreliosis. J Neuroimmunol 131: 173–178.[ISI][Medline]
  11. Craig-Mylius K, Weber GF, Coburn J, Glickstein L, 2005. Borrelia burgdorferi, an extracellular pathogen, circumvents osteopontin in inducing an inflammatory cytokine response. J Leukoc Biol 77: 710–718.[Abstract/Free Full Text]
  12. Montgomery RR, Malawista SE, 1996. Entry of Borrelia burgdorferi into macrophages is end-on and leads to degradation in lysosomes. Infect Immun 64: 2867–2872.[Abstract]
  13. Coburn J, Leong JM, Erban JK, 1993. Integrin {alpha}IIb ß3 mediates binding of the Lyme disease agent Borrelia burgdorferi to human platelets. Proc Natl Acad Sci U S A 90: 7059–7063.[Abstract/Free Full Text]
  14. Coburn J, Chege W, Magoun L, Bodary SC, Leong JM, 1999. Characterization of a candidate Borrelia burgdorferi ß3-chain integrin ligand identified using a phage display library. Mol Microbiol 34: 926–940.[ISI][Medline]
  15. Kinjyo I, Hanada T, Inagaki-Ohara K, Mori H, Aki D, Ohishi M, Yoshida H, Kubo M, Yoshimura A, 2002. SOCS1/JAB is a negative regulator of LPS-induced macrophage activation. Immunity 17: 583–591.[ISI][Medline]
  16. Ciaramella A, Cavone A, Santucci MB, Amicosante M, Martino A, Auricchio G, Pucillo LP, Colizzi V, Fraziano M, 2002. Proinflammatory cytokines in the course of Mycobacterium tuberculosis-induced apoptosis in monocytes/macrophages. J Infect Dis 186: 1277–1282.[ISI][Medline]
  17. Glickstein LJ, Huber BT, 1995. Karoushi – death by overwork in the immune system. J Immunol 155: 522–524.[ISI][Medline]
  18. Zeidner N, Mbow ML, Dolan M, Massung R, Baca E, Piesman J, 1997. Effects of Ixodes scapularis and Borrelia burgdorferi on modulation of the host immune response: induction of a TH2 cytokine response in Lyme disease-susceptible (C3H/HeJ) mice but not in disease-resistant (BALB/c) mice. Infect Immun 65: 3100–3106.[Abstract]
  19. Zeidner N, Dreitz M, Belasco D, Fish D, 1996. Suppression of acute Ixodes scapularis-induced Borrelia burgdorferi infection using tumor necrosis factor-alpha, interleukin-2, and interferon- gamma. J Infect Dis 173: 187–195.[ISI][Medline]
  20. Barthold SW, Sidman CL, Smith AL, 1992. Lyme borreliosis in genetically resistant and susceptible mice with severe combined immunodeficiency. Am J Trop Med Hyg 47: 605–613.[Abstract/Free Full Text]
  21. Schaible UE, Kramer MD, Wallich R, Tran T, Simon MM, 1991. Experimental Borrelia burgdorferi infection in inbred mouse strains: antibody response and association of H-2 genes with resistance and susceptibility to development of arthritis. Eur J Immunol 21: 2397–2405.[ISI][Medline]
  22. Weis JJ, McCracken BA, Ma Y, Fairbairn D, Rober RJ, Morrison TB, Weis JH, Zachary JF, Dorge RW, Teuscher C, 1999. Identification of quantitative trait loci governing arthritis severity and humoral responses in the murine model of Lyme disease. J Immunol 162: 948–956.[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
J. Immunol.Home page
D. Li, Y. Li, X. Wu, Q. Li, J. Yu, J. Gen, and X.-L. Zhang
Knockdown of Mgat5 Inhibits Breast Cancer Cell Growth with Activation of CD4+ T Cells and Macrophages
J. Immunol., March 1, 2008; 180(5): 3158 - 3165.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
A. R. Cruz, M. W. Moore, C. J. La Vake, C. H. Eggers, J. C. Salazar, and J. D. Radolf
Phagocytosis of Borrelia burgdorferi, the Lyme Disease Spirochete, Potentiates Innate Immune Activation and Induces Apoptosis in Human Monocytes
Infect. Immun., January 1, 2008; 76(1): 56 - 70.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (2)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by GLICKSTEIN, L. J.
Right arrow Articles by COBURN, J. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by GLICKSTEIN, L. J.
Right arrow Articles by COBURN, J. L.
Related Collections
Right arrow Borrelia
Right arrow Lyme Disease


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS